Bioprocess Equipment For Commercial Manufacturing
Transition seamlessly from R&D to clinical and commercial manufacturing with our bioprocess equipment.
Translate your R&D upstream bioprocess achievements into clinical and commercial manufacturing success with our integrated solutions. Our streamlined package includes bioprocess controllers, bioreactors, bioprocess SCADA software, and services, allowing you to conduct both R&D and manufacturing processes on a uniļ¬ed platform while supporting compliance with GMP requirements.
Seamlessly transition from R&D to clinical and commercial manufacturing
Maintain consistency and quality as you scale-up. The BioFlo 320 in combination with BioBLU HNQ Single-Use Bioreactors enable a more than 100-fold scale-up on a single platform and ensures that your R&D successes translate seamlessly into manufacturing. In combination with the BioFlo 720 bioreactor control system, the BioFlo platform supports one of the widest ranges of single-use solutions, allowing the scale-up of your process to up to 500 L.
Get support to comply with legal requirements and standards
Our global qualification and certification services with comprehensive documentation ensure the functioning of your instruments according to the specified parameters. Simplify compliance with our bioprocessing qualification services. Focus on innovation while we support you with your compliance to GMP requirements.
Maximize data integrity and traceability
With DASware control plus bioprocess SCADA software you benefit from a centralized source for bioprocess data collection, control, and storage, ensuring data integrity and traceability with 21 CFR Part 11 and EudraLex Volume 4 Annex 11 compatibility.
Combine the trusted performance of stirred- tank design with the advantages of one-time use
Take advantage of single-use technology for biopharmaceutical applications with our BioBLU HNQ Single-Use Bioreactors. These rigid-walled stirred-tank bioreactors are a true replacement for traditional glass bioreactors. Smooth the transition to manufacturing with the HNQ variants that are suitable for clinical and commercial manufacturing.